Rates of individual evidence-based recommendations among cases and controls
| Cases (n=1716) | Controls (n=3432) | p Value | |||
| n | % | n | % | ||
| Cardiac catheterisation | 692 | 40.9 | 1772 | 51.9 | <0.001 |
| PCI | 329 | 19.3 | 1111 | 32.5 | <0.001 |
| Coronary artery bypass graft surgery | 49 | 2.9 | 150 | 4.4 | 0.01 |
| ACE inhibitor | 1148 | 67.4 | 2321 | 68.0 | 0.68 |
| Aspirin | 1563 | 91.2 | 3194 | 93.1 | 0.02 |
| β-Blocker | 1340 | 79.0 | 2775 | 81.3 | 0.05 |
| Clopidogrel | 661 | 39.0 | 1705 | 50.0 | <0.001 |
| Intravenous glycoprotein IIb/IIIa inhibitor | 299 | 17.7 | 821 | 24.2 | <0.001 |
| Statin | 951 | 55.7 | 2097 | 61.6 | <0.001 |
| Referral to cardiac rehabilitation | 302 | 23.7 | 752 | 28.5 | 0.001 |